The sodium-glucose cotransporter 2 (SGLT2) is a protein increased by over-inflammation in patients with type 2 diabetes mellitus and implied in the process of atherosclerotic plaque destabilization and rupture [1]. Here, SLC5A2 is linked to diabetes mellitus.